Last year, a study reported that diabetes patients using GLP-1 drugs could face a twofold higher risk of developing age-related macular degeneration
Researchers rose to the challenge thanks to an unlikely source, the Gila monsters saliva
L- ,
To reinforce these findings, we also measured the release of lactate from muscle using a flow system (Fig
Its an easy, consistent capsule for everyday routines that value absorption, tolerance, and ingredient integrity
Key points GLP-1 is a hormone that increases insulin release and prevents the release of too much glucagon, helping manage blood glucose levels in individuals with type 2 diabetes GLP-1 receptor agonists, such as liraglutide and semaglutide, effectively reduce blood glucose levels Semaglutide is more effective than liraglutide at reducing blood sugar levels Tirzepatide is a newer GLP-1 receptor agonist that also mimics the actions of another hormone called GIP, which can also reduce blood sugar levels A randomised controlled trial showed that tirzepatide led to more significant blood sugar reductions than semaglutide across three doses Tirzepatide may be more effective than semaglutide at higher doses, but this needs further investigation Liraglutide and semaglutide are available in the UK and the US, while tirzepatide is only available in the US but is likely to be approved in the UK soon
